Get started
Author

Tiongsun Chia

Total synthesis of Escherichia coli with a recoded genome
2019 · Julius Fredens, Kaihang Wang, et al. · Nature · 539
Defining synonymous codon compression schemes by genome recoding
2016 · Kaihang Wang, Julius Fredens, et al. · Nature · 171
An artificial PPR scaffold for programmable RNA recognition
2014 · Sandrine Coquille, Aleksandra Filipovska, et al. · Nature Communications · 128
PDF
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2023 · Weiwei Wu, Tiongsun Chia, et al. · Nature Cancer · 87
Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice
2012 · Julia I. Ellyard, Tiongsun Chia, et al. · Blood · 50
PDF
Estrogen-Mediated Regulation of Mitochondrial Gene Expression
2014 · Maria I. G. Lopez Sanchez, Anne-Marie J. Shearwood, et al. · Molecular Endocrinology · 45
Modular ssDNA binding and inhibition of telomerase activity by designer PPR proteins
2018 · Henrik Spåhr, Tiongsun Chia, et al. · Nature Communications · 25
PDF
Artificial intelligence and polyp detection in colonoscopy: Use of a single neural network to achieve rapid polyp localization for clinical use
2021 · James Weiquan Li, Tiongsun Chia, et al. · Journal of Gastroenterology and Hepatology · 23
Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
2022 · Huisi Liu, Weiwei Wu, et al. · Cell Reports Medicine · 6
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
2026 · Jian Guan, Tiongsun Chia, et al. · Nature Communications · 3
PDF
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
2026 · Jia Liu, Jingbo Ma, et al. · Cancer Research
Abstract 4249: IBI3019, a first-in-class EGFR/CDH17/CD16A tri-specific antibody, demonstrated potent efficacy against CRC and an excellent safety profile in preclinical studies
2025 · Tiongsun Chia, Weiwei Wu, et al. · Cancer Research
Works count: 12
Citation count: 1,077
H-index: 8
I10-index: 8
Year
Topic
Type